Past seminars

What's New In Therapeutics- 27 January 2025

Chair: Prof Chloe James (Chair in Microbiology, University of Salford)

13:00 - 13:05

Welcome and introduction

Prof Chloe James (Chair in Microbiology, University of Salford) 

13:05 - 13:25 

Panel introduction

Panellists:

  • Prof Jo Fothergill (Director of Microbiomes Centre, Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool)                                                           
  • Prof Shampa Das (Head of Dept of Pharmacology & Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool) 
  • Dr Clare Trippett (Principal Strategic Opportunities Manager, CPI)
  • Dr Deborah O’Neil (Chief Executive Officer, NovaBiotics Ltd)

13:25 - 13:45

Panel discussion

Panellists

13:45 - 13:55

Q&A session

Panellists

13:55 - 14:00

Closing remarks

Prof Chloe James (Chair in Microbiology, University of Salford) 

What regulators want you to know - 25 November 2024

Chair: Carmen Coxon (Medicines and Healthcare Regulatory Agency, UK)            
 

14:00 - 14:05 Welcome and introduction

Carmen Coxon (Medicines and Healthcare Regulatory Agency, UK)
14:05 - 14:10 The role of the MHRA and how we support AMR research and innovation

Carmen Coxon (Medicines and Healthcare Regulatory Agency, UK)
14:10 - 14:15 AMR surveillance of the food chain

Kathryn Callaghan (Food Standards Agency, UK)
14:15 - 14:25

Health, safety and environmental considerations for AMR product developers


Sean Simpkins (Department for Environment Food and Rural Affairs, UK)

14:25 - 14:30

Considering AMR in low- and middle-income countries (LMICs)


Sheetal Ghelani (Clinton Health Access Initiative, USA)

14:30 - 14:55 Q&A with panel
14:55 - 15:00 14:55 - 15:00

 

Opportunities for Diagnostics Research - 22 October 2024

Chair: Tina Joshi, Associate Professor of Molecular Microbiology, Co-Chair of Knocking Out AMR Project

13:00–13:15

PACE: 2024 Diagnostic Innovations funding call

Clive Mason, PACE Programme Director, AMR 

13:15–13:30 

Microplate Dx research

Paul Hoskisson, Microplate Dx Chief Scientific Advisor/ University of Strathclyde 

13:30–13:45 

Research opportunities in AMR Diagnostics

Helen Dent, BIVDA

13:45–14:00

Panel Q&A

 

Engaging with Policymakers on AMR – 16 September 2024

Chair: Emily Hugo-Webb (Policy and Engagement Manager, Microbiology Society)

13:00–13:15

An introduction to engaging with policymakers

Emily Hugo-Webb (Policy and Engagement Manager, Microbiology Society)

13:15–13:20

My experience of engaging with policymakers

Frances Spragge (Microbiology Society Parliamentary Internship)

13:20–13:25

My experience of engaging with policymakers

Frances Spragge (Microbiology Society Parliamentary Internship)

13:25–13:35

Moving from academia to science policy; opinions on future of AMR policy

Prof Robin May (Microbiology Society member; Chief Scientific Advisor at the Food Standards Agency)

13:35–13:45

The UK NAP and how to engage with it

Connie Longmate (Team lead – IPC and AMR Department of Health and Social Care)

13:45–13:55

UNGA: What it is, how to get involved, what will be discussed

AMR Multi-Stakeholder Partnership Platform Representative

13:55–14:00

Closing remarks and call to action

Emily Hugo-Webb (Policy and Engagement Manager, Microbiology Society)